LY334370

目录号: PL01387 纯度: ≥99%
LY334370 是一个选择性的 5-HT1F 受体激动剂,其 Ki 值为 1.6 nM。
CAS No. :182563-08-2
商品编号 规格 价格 会员价 是否有货 数量
PL01387-5mg 5mg ¥273.00 请登录
PL01387-10mg 10mg ¥412.00 请登录
PL01387-25mg 25mg ¥926.00 请登录
PL01387-50mg 50mg ¥1365.00 请登录
PL01387-100mg 100mg ¥1995.00 请登录
PL01387-200mg 200mg ¥2765.00 请登录
PL01387-500mg 500mg 询价 询价
PL01387-1 mL x 10 mM (in DMSO) 1 mL x 10 mM (in DMSO) ¥301.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
LY334370
中文别名
4-氟-N-(3-(1-甲基哌啶-4-基)-1H-吲哚-5-基)苯甲酰胺盐酸盐;4-氟-n-(3-(1-甲基哌啶-4-基)-1H-吲哚-5-基)苯脒盐酸盐
英文名称
LY334370
英文别名
4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]-Benzamide;4-fluoro-N-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]benzamide;LY 334370 HYDROCHLORIDE;LY 334370;LY-334370 hydrochloride hydrate;4-Fluoro-N-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)benazmide;4-Fluoro-N-[3-(1-methyl-piperidin-4-yl)-1H-indol-5-yl]-benzamide;BenzaMide, 4-fluoro-N-[3-(1-Methyl-4-piperidinyl)-1H-indol-5-yl]-;4-Fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamidehydrochloride;4-Fluoro-N-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)benazmide hydrochloride;4-Fluoro-N-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)benzamide hydrochloride;4-Fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide hydrochloride hydrate;LY334370
Cas No.
182563-08-2
分子式
C21H22N3OF
分子量
351.42
包装储存
4°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
详情描述

LY334370 是一个选择性的 5-HT1F 受体激动剂,其 Ki 值为 1.6 nM。

产品详情
LY334370 是一个选择性的 5-HT1F 受体激动剂,其 Ki 值为 1.6 nM。
生物活性
LY334370 is a selective 5-HT 1F receptor agonist with a K i of 1.6 nM.
性状
Solid
IC50 & Target[1][2]
5-HT1F Receptor 1.6 nM (Ki)
体外研究(In Vitro)
LY334370 has no vasoconstrictor effects on human cerebral arteries in vitro until a dose of 10 M, at which it produces a contraction of 8.5±5.7%; however, this is not significant. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Following intravenous administration of LY334370 at 3 mg/kg (n=3) or 10 mg/kg (n=6) electrical stimulation evokes an increase in dural blood vessel diameter of 135±6% and 106±11%, respectively, which is not significantly different from the respective control values. LY334370 has no effect on dural blood vessel diameter per se, since the actual dural blood vessel diameter is 43±4 arbitrary units before drug and 43±4 arbitrary units 15 min after injection of LY334370 (10 mg/kg). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, stored under nitrogen In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
参考文献
[1]. Shepheard S, et al. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia. 1999 Dec;19(10):851-8.
溶解度数据
In Vitro: DMSO : ≥ 55.5 mg/mL (157.93 mM)配制储备液
搜索质检报告(COA)
[1]. Shepheard S, et al. Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia. 1999 Dec;19(10):851-8.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2